ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sartorius Stedim Biotech and Repligen Corporation Partner to Introduce Next-Generation Perfusion-Enabled Bioreactors
September 06, 2018Sartorius Stedim Biotech and Repligen Corporation have entered into a collaboration agreement to integrate Repligen’s XCell™ ATF cell retention control technology into SSB’s BIOSTAT® STR large-scale single-use bioreactors to create novel perfusion-enabled
Pharma Sources Insight January 2025
